Skyhawk Reports 12-Month Phase 1/2 Results for SKY-0515
BOSTON, Massachusetts, June 30, 2026 Skyhawk Therapeutics has announced encouraging 12-month interim results from its ongoing Phase 1/2 clinical...
Cosmeceuticals
Advertisement
Ribo, Madrigal Advance siRNA Therapy for MASH Treatment
SUZHOU, China, and MÖLNDAL, Sweden, July 2, 2026 Suzhou Ribo Life Science Co., Ltd. and its subsidiary Ribocure Pharmaceuticals...
Trilogy Laboratories Acquires YNS Cosmeceuticals
FORT MYERS, Florida, July 2, 2026 Trilogy Laboratories has announced the acquisition of YNS Cosmeceuticals, a respected skincare brand...
Oriflame’s New Research Reveals Oripeptide-3’s Impact on Skin Longevity
London, UK – November 12, 2025 — Oriflame announced the results of new research demonstrating the effects of its...
Advertisement
